tiratricol   Click here for help

GtoPdb Ligand ID: 2637

Synonyms: 3,3',5-triiodothyroacetic acid | Emcitate® | TRIAC
Approved drug PDB Ligand
tiratricol is an approved drug
Compound class: Metabolite
Comment: Tiratricol is a thyroid hormone analogue.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 66.76
Molecular weight 621.76
XLogP 5.73
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)Cc1cc(I)c(c(c1)I)Oc1ccc(c(c1)I)O
Isomeric SMILES OC(=O)Cc1cc(I)c(c(c1)I)Oc1ccc(c(c1)I)O
InChI InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)
InChI Key UOWZUVNAGUAEQC-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
In February 2025, the EU EMA authorised use of tiratricol to treat peripheral thyrotoxicosis in pateints with monocarboxylate transporter 8 (MCT8) deficiency [1]. It is also administered to manage thyroid hormone resistance syndrome. It has also been used in preparations claiming to aid weight loss, but public health agencies have warned against such use. US FDA approval for thyrotoxicosis in MCT8 deficiency was granted in September 2026.